Endpoints 11 2026 winner Medici believes the future of cancer therapy is personalized
The next big breakthrough in ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
More in Health & Medicine
Endpoints 11 2026 winner Corsera is the latest big bet by Maraganore and Meanwell
Veteran bio leaders Clive Meanwell and John Maraganore ...
Biotech's best startups of 2026: Meet this year's Endpoints 11
The Endpoints 11 awards are our chance to tell a story about where biotech is going. In some ways, biotech feels like it has finally emerged from years of uncertainty. The money that fuels the ...
Endpoints 11 2026 winner K2 Therapeutics looks to marry China’s speed with global expertise
A small drug developer with ...
Endpoints 11 2026 winner SonoThera has a new approach to non-viral gene therapy
Key leaders Kenneth Greenberg (CEO), Steve Feinstein (CSO) Headquarters San Francisco Total raised $186M Key investors Vida Ventures, ARCH Ventures Partners, Illumina Ventures, Leaps by Bayer, Johnson…
Endpoints 11 2026 winner Medra wants to create self-driving labs
Shortly after earning a PhD in robotics ...
Endpoints 11 2026 winner Stipple Bio is taking precision to the next level
Pancreatic cancer treatment is ...